The data indicates a downward trend in hospital discharges for leiomyoma of the uterus in France, forecasted from 28.4 thousand in 2024 to 26.43 thousand in 2028. In 2023, actual discharges stood at 28.9 thousand. Year-on-year variations reveal a consistent annual decrease, signaling a gradual decline in the incidence or reporting of this condition. The last two years show an average decrease of 1.75%, and the five-year CAGR indicates an average annual reduction of 1.79%.
Future trends to watch for include advancements in non-surgical treatments, changes in healthcare policies, or population demographics that could influence hospital discharge rates related to uterine leiomyoma.
